Supplementary Figure 5 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
Year: 2024
Type: supplementary-materials
Abstract: This figure shows the selection of cell lines used for in vitro evaluation of the effects of amivantamab on the protein and surface levels EGFR, MET, LDHA and SLC16A3.
Authors: Sun M. Lim, Seong-san Kang, Dong K. Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin Na, Young T. Kim, Mi R. Yun, Jae H. Kim, Youngseon Byeon, Young S. Kim, Jii B. Lee, Min H. Hong, Joshua C. Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung C. Cho
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4400734809